BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2003
View Archived Issues
New glucose-lowering agents covered by BMS patent
Read More
Merck KGaA presents new agents able to inhibit PDE4 and TNF-alpha production
Read More
New factor Xa and/or factor VIIa inhibitors under study at Merck KGaA
Read More
Rigel researchers present novel anti-HCV agents
Read More
Agents for iron overload therapy disclosed by Novartis researchers
Read More
Enanta develops new macrolides
Read More
Novel antiangiogenic combretastatin analogues with utility in cancer therapy
Read More
Celsion treats first patient in Thermodox trial for prostate cancer
Read More
Milnacipran has distinct mechanisms for effects on pain and mood
Read More
Prefilled Avonex syringe approved
Read More
Lescol and Lescol XL approved for new indication
Read More
Corixa and GSK enter Bexxar agreement for Canada
Read More
Asimadoline reduces pain threshold associated with colon distension in IBS
Read More
Improved hemodynamics reported with sitaxsentan in pulmonary hypertension
Read More
SR-140333B effective and well tolerated in ulcerative colitis
Read More
Good efficacy and cardiovascular safety profile reported for cilomilast in COPD
Read More
Pregabalin improves anxiety scores and work productivity in GAD
Read More
Inflazyme acquisition of GlycoDesign approved
Read More
Amgen and Tularik form oncology collaboration
Read More
Allos updates operating plan for 2003
Read More
Cardiome plans phase III for RSD-1235
Read More
Pharma Mar advances kahalalide F into phase II for liver carcinoma
Read More
Levaquin approved for treatment of chronic bacterial prostatitis
Read More
Orally active, small-molecule CXCR3 antagonist represents a new class of transplant therapeutics
Read More
NC-1153: a novel immunosuppressant that selectively targets Jak3
Read More